BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8693289)

  • 1. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
    Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
    Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin.
    Werfel T; Zwirner J; Oppermann M; Sieber A; Begemann G; Drommer W; Kapp A; Götze O
    J Immunol; 1996 Aug; 157(4):1729-35. PubMed ID: 8759762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
    Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
    J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
    Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P
    J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.
    Kacani L; Bánki Z; Zwirner J; Schennach H; Bajtay Z; Erdei A; Stoiber H; Dierich MP
    J Immunol; 2001 Mar; 166(5):3410-5. PubMed ID: 11207298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
    Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
    J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of C5a receptor in mouse microvascular endothelial cells.
    Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA
    J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system.
    Gasque P; Singhrao SK; Neal JW; Götze O; Morgan BP
    Am J Pathol; 1997 Jan; 150(1):31-41. PubMed ID: 9006319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells.
    Wetsel RA
    Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
    Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
    J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5a receptor expression by TGW neuroblastoma cells.
    Farkas I; Baranyi L; Kaneko Y; Liposits Z; Yamamoto T; Okada H
    Neuroreport; 1999 Sep; 10(14):3021-5. PubMed ID: 10549816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.
    Ali H; Ahamed J; Hernandez-Munain C; Baron JL; Krangel MS; Patel DD
    J Immunol; 2000 Dec; 165(12):7215-23. PubMed ID: 11120854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg).
    Zwirner J; Götze O; Sieber A; Kapp A; Begemann G; Zuberbier T; Werfel T
    Scand J Immunol; 1998 Jan; 47(1):19-24. PubMed ID: 9467653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells.
    Fayyazi A; Sandau R; Duong LQ; Götze O; Radzun HJ; Schweyer S; Soruri A; Zwirner J
    Am J Pathol; 1999 Feb; 154(2):495-501. PubMed ID: 10027407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and induction of anaphylatoxin C5a receptors in the rat liver.
    Schlaf G; Schmitz M; Rothermel E; Jungermann K; Schieferdecker HL; Götze O
    Histol Histopathol; 2003 Jan; 18(1):299-308. PubMed ID: 12507307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the anaphylatoxin C5a receptor in non-myeloid cells.
    Zwirner J; Fayyazi A; Götze O
    Mol Immunol; 1999; 36(13-14):877-84. PubMed ID: 10698342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.